-transparent.png){kind=logo}
De novo renal cell carcinoma in a renal allograft is rare and has special implications in renal transplant recipients. We describe a patient with a renal allograft who developed a de novo renal cell carcinoma in the functioning renal allograft 258 months after transplantation. The patient underwent enucleation of the tumor because preoperative MRI showed it was well-encapsulated. A DNA banding study showed that the tumor originated from the donor. Indications for conservative renal surgery in renal cell carcinoma have been increasing. Accordingly, 1 option in the treatment of de novo renal cell carcinoma in a functioning renal allograft is enucleation as a method of nephron sparing surgery.
K I Park, and
H Inoue, and
C J Kim, and
T Tomoyoshi
December 2014,
Progress in transplantation (Aliso Viejo, Calif.),
K I Park, and
H Inoue, and
C J Kim, and
T Tomoyoshi
September 2005,
Transplantation,
K I Park, and
H Inoue, and
C J Kim, and
T Tomoyoshi
August 2017,
Transplantation direct,
K I Park, and
H Inoue, and
C J Kim, and
T Tomoyoshi
February 2004,
Transplantation,
K I Park, and
H Inoue, and
C J Kim, and
T Tomoyoshi
January 2020,
Urologia internationalis,
K I Park, and
H Inoue, and
C J Kim, and
T Tomoyoshi
October 2007,
World journal of urology,
K I Park, and
H Inoue, and
C J Kim, and
T Tomoyoshi
January 2004,
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
K I Park, and
H Inoue, and
C J Kim, and
T Tomoyoshi
January 2007,
Scandinavian journal of urology and nephrology,
K I Park, and
H Inoue, and
C J Kim, and
T Tomoyoshi
May 1993,
Seminars in urology,
K I Park, and
H Inoue, and
C J Kim, and
T Tomoyoshi
January 1999,
Reviews in urology,
